Navigation Links
Can Obama Plan Tackle Diabetes Crisis? Epinex Test Could Help
Date:3/10/2009

IRVINE, Calif., March 10 /PRNewswire/ -- Diabetes will be a huge burden on President Obama's $634 billion plan to expand and improve healthcare coverage. Epinex Diagnostics, a private biomedical company located in Irvine, California, has developed a new diabetes monitoring device that could relieve the burden of diabetes on our healthcare system.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090310/LA81722)

The Epinex G1A(TM) Rapid Diabetes Monitoring Index Test is a revolutionary monthly rapid test that uses glycated albumin to measure how much damage has been done to the body by excess sugar. The Epinex G1A(TM) test will be a significant asset to help keep costs down by introducing a monthly testing paradigm that has been proven effective. This test could allow doctors to take action sooner than current diabetes testing methods, reducing the severity and cost of diabetes and its complications, which include blindness, kidney failure and cardiac disease.

President Obama recently acknowledged, "crushing health care costs...drag down our economy, bankrupt our families, and represent the fastest-growing part of our budget." In an unprecedented commitment to a new, more effective approach to healthcare, the President has taken the challenge to keep raging costs under control by proposing the "largest investment ever" in preventive care.

Diabetes eats up an enormous chunk of our current healthcare resources. It has become the greatest healthcare crisis of our time, affecting one in three Americans. Last year alone, direct medical costs for diabetes totaled $116 billion, a 32% increase since 2002. Despite current efforts to manage the epidemic, the toll of diabetes continues to spiral out of control. However, pouring more resources into ineffective programs will only waste money.

Continuing to address the diabetes epidemic using methods of the past threatens to set up our health care system for failure. "The current treatment paradigm for diabetes doesn't work," explains Epinex CEO, Asad Zaidi. "With our current financial crisis, Epinex is working on a product that will help save our already over-burdened healthcare system billions of dollars, while helping diabetics manage their disease more effectively."

About Epinex Diagnostics, Inc.

Epinex Diagnostics is a privately owned medical device company with a vision to help alleviate the current healthcare crisis through the development of innovative point-of-care technologies using rapid diagnostic tests. Please find further information about the company and the G1A(TM) test at www.epinex.com.


'/>"/>
SOURCE Epinex Diagnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Cord Blood America Sees Significant Positives in President Obamas Lifting of Stem Cell Funding Restrictions
2. Environmental Tectonics Corporations BioMedical Divisions Hyperbaric Chambers Address U.S. President Obamas Initiative to Computerize Medical Records
3. Obama Advisor Joins Connecticut and International Scientists at New Haven Stem Cell Symposium
4. Growing Interest in DNA-Based Genetic Testing Among African American with Historic Election of President Elect Barack Obama
5. Cord Blood America Salutes President-Elect Obamas Promise to Lift Restrictions on Stem Cell Research
6. McCain and Obama on Bio-threat Detection and Pandemic Response: QualSec Weighs in
7. Old and new therapies combine to tackle atherosclerosis
8. World Hepatitis Alliance Calls on Governments to Take Urgent Action to Tackle Chronic Viral Hepatitis B & C Epidemic
9. New Report Tackles the Changing Landscape for Alzheimers Diagnostics and Treatments
10. Atherotech Announces Addition of ApoAI Heart Disease, Diabetes Risk Marker to VAP(R) Test
11. Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, ... microbial test has received AOAC Research Institute approval 061601. , “This is another ... year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample ... the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity ...
(Date:6/23/2016)... 2016 On Wednesday, June 22, 2016, ... 0.22%; the Dow Jones Industrial Average edged 0.27% lower to ... down 0.17%. Stock-Callers.com has initiated coverage on the following equities: ... (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing their ...
(Date:6/23/2016)... India , June 23, 2016 ... media market research report to its pharmaceuticals section ... profiles, product details and much more. ... spread across 151 pages, profiling 15 companies and ... available at http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . ...
Breaking Biology Technology:
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
(Date:4/14/2016)... AVIV, Israel , April 14, 2016 ... Behavioral Authentication and Malware Detection, today announced the appointment ... already assumed the new role. Goldwerger,s leadership ... BioCatch, on the heels of the deployment of its ... addition, BioCatch,s behavioral biometric technology, which discerns unique cognitive ...
Breaking Biology News(10 mins):